| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.02 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.02 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.14 | 0.02 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Zibotentan | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.082 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.03 |